Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (321-330 of 365) with videos related to

Pageof 37
Sort By:
JAMA Neurology|July 30, 2022
Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive ImpairmentCherie Strikwerda-Brown, Diana A Hobbs, Julie Gonneaud, et al.
Neurology|November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older IndividualsLaura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
The Lancet. Neurology|January 15, 2008
Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanismChristopher C Rowe, Uwe Ackerman, William Browne, et al.
International Psychogeriatrics|November 21, 2013
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)Kathryn A Ellis, Cassandra Szoeke, Ashley I Bush, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2018
Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-βW M A D Binosha Fernando, Stephanie R Rainey-Smith, Samantha L Gardener, et al.
Nature Communications|September 12, 2024
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer's disease progressionXin Huang, Chris Fowler, Yihan Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2022
Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's diseaseXin Huang, Yihan Li, Christopher Fowler, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectivesChristopher J Weber, Maria C Carrillo, William Jagust, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Pageof 37

Showing results (321-330 of 365) with videos related to

Sort By:
Pageof 37
JAMA Neurology|July 30, 2022
Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive ImpairmentCherie Strikwerda-Brown, Diana A Hobbs, Julie Gonneaud, et al.
Neurology|November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older IndividualsLaura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
The Lancet. Neurology|January 15, 2008
Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanismChristopher C Rowe, Uwe Ackerman, William Browne, et al.
International Psychogeriatrics|November 21, 2013
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)Kathryn A Ellis, Cassandra Szoeke, Ashley I Bush, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2018
Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-βW M A D Binosha Fernando, Stephanie R Rainey-Smith, Samantha L Gardener, et al.
Nature Communications|September 12, 2024
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer's disease progressionXin Huang, Chris Fowler, Yihan Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 9, 2022
Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's diseaseXin Huang, Yihan Li, Christopher Fowler, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 10, 2022
The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectivesChristopher J Weber, Maria C Carrillo, William Jagust, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Pageof 37